ArticleThe Lancet. Neurology2020
Interleukin-6 receptor blockade for the treatment of NMOSD.
Michael LevyPubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleThe Lancet. Neurology2020
Michael LevyPubMed ↗Publisher ↗
No numbers read from the abstract.